SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-060859
Filing Date
2015-08-19
Accepted
2015-08-19 08:31:42
Documents
14
Period of Report
2015-08-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-18164_18k.htm 8-K 21265
2 EX-99.1 a15-18164_1ex99d1.htm EX-99.1 22759
3 GRAPHIC g181641mmi001.gif GRAPHIC 36106
4 GRAPHIC g181641mmi002.gif GRAPHIC 149139
5 GRAPHIC g181641mmi003.gif GRAPHIC 42183
6 GRAPHIC g181641mmi004.gif GRAPHIC 60992
7 GRAPHIC g181641mmi005.gif GRAPHIC 78128
8 GRAPHIC g181641mmi006.gif GRAPHIC 95639
9 GRAPHIC g181641mmi007.gif GRAPHIC 74801
10 GRAPHIC g181641mmi008.gif GRAPHIC 86008
11 GRAPHIC g181641mmi009.gif GRAPHIC 68518
12 GRAPHIC g181641mmi010.gif GRAPHIC 102763
13 GRAPHIC g181641mmi011.gif GRAPHIC 62897
14 GRAPHIC g181641mmi012.gif GRAPHIC 38792
  Complete submission text file 0001104659-15-060859.txt   1280037
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 151062934
SIC: 2834 Pharmaceutical Preparations